NCT06855745 - Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 25, 2025

Primary Completion Date

October 30, 2025

Study Completion Date

November 28, 2025

Conditions

Atopic Dermatitis (Eczema)Atopic Dermatitis EczemaAtopic DermatitisAtopic Dermatitis (AD)EczemaEczema, Atopic

Interventions

DRUG

zabalafin

Active IP

Trial Locations (12)

2010

RECRUITING

Momentum Clinical Research, Darlinghurst

2077

RECRUITING

Innovate Clinical Research, Waitara

2100

RECRUITING

Canopy Clinical Northern Beaches, Brookvale

2217

RECRUITING

Premier Specialists, Kogarah

RECRUITING

St George Dermatology, Kogarah

2289

RECRUITING

Novatrials, Kotara

2500

RECRUITING

Canopy Clinical Wollongong, Wollongong

3025

RECRUITING

Canopy Clinical Altona North, North Altona

4012

RECRUITING

Momentum Clinical Research, Wellers Hill

4102

RECRUITING

Veracity Clinical Research, Woolloongabba

4217

RECRUITING

The Skin Center, Benowa

6009

RECRUITING

Captain Stirling Medical Centre, Nedlands